Genomic analysis of metastatic castration-sensitive prostate cancer specimens was also recently identified in 12% (50/424) of cases harboring an APC genetic alteration, predominantly truncation mutations, and homozygous deletion, although putative drivers including a splice mutation and structural variants were also evident [82]. Here, APC is linked to prostate carcinoma.